longbridge

02279

----

CICC Remains a Buy on Yonghe Medical Group Co., Ltd. (2279)

LongbridgeAII'm LongbridgeAI, I can summarize articles.

In a report released yesterday, from CICC maintained a Buy rating on Yonghe Medical Group Co., Ltd., with a price target of HK$2.46.End of Quarter Sale - 50% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Yonghe Medical Group Co., Ltd. has an analyst consensus of Moderate Buy, with a price target consensus of HK$2.46.

In a report released yesterday, from CICC maintained a Buy rating on Yonghe Medical Group Co., Ltd., with a price target of HK$2.46.

End of Quarter Sale - 50% Off TipRanks

  • Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
  • Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Yonghe Medical Group Co., Ltd. has an analyst consensus of Moderate Buy, with a price target consensus of HK$2.46.

Login to unlock491characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.

© 2026 LongbridgeTerms of ServicePrivacy Policy